unloxcyt
Generic: cosibelimab-ipdl·Code: cosibelimab-ipdl
unloxcyt: developed by 2 companies. Updated within the last hour.
Development Pipeline (3)
| Company | Phase |
|---|---|
| Checkpoint Therapeutics, Inc. (CKPT) | Approved |
| Fortress Biotech Inc. (FBIO) | Approved |
| Fortress Biotech Inc. (FBIO) | Approved |
Get deeper analysis on unloxcyt
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis